首页> 外文OA文献 >Use of Bivalirudin During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus An Analysis From the Randomized Evaluation in Percutaneous Coronary Intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 Trial

【2h】

Use of Bivalirudin During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus An Analysis From the Randomized Evaluation in Percutaneous Coronary Intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 Trial

机译：比伐卢定在糖尿病患者经皮冠状动脉介入治疗中的应用从经皮冠状动脉介入治疗与血管生成素减少与临床事件减少相关的随机评估（REPLACE）-2试验中分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Gurm Hitinder S.; Sarembock Ian J.; Kereiakes Dean J.; Young John J.; Harrington Robert A.; Kleiman Neal; Feit Frederick; Wolski Kathy; Bittl John A.; Wilcox Robert; Topol Eric J.; Lincoff A. Michael;
展开▼
作者单位

展开▼
年度 2005
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. [J] . Mehran R, Pocock S, Nikolsky E, JACC. Cardiovascular interventions . 2011,第6期

机译：经皮冠状动脉介入治疗后出血对死亡率的影响来自于对REPLACE-2（PCI将血管造影与减少临床事件的关联性的随机评估），ACUITY（急性导管插入和紧急干预分类策略）的患者水平汇总分析和HORIZONS-AMI （在急性心肌梗死中采用血运重建术和支架使结果一致）试验。
2. Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials (vol 15, pg 275, 2015) [J] . Ibebuogu Uzoma N., Bolorunduro Oluwaseyi, Giri Smith, American journal of cardiovascular drugs: drugs, devices, and other interventions . 2015,第4期

机译：比伐卢定与肝素加糖蛋白IIb / IIIa抑制剂在接受经皮冠状动脉介入治疗的糖尿病患者中的作用：一项随机对照试验的荟萃分析（第15卷，第275页，2015年）
3. Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [J] . Ibebuogu Uzoma N., Bolorunduro Oluwaseyi, Giri Smith, American journal of cardiovascular drugs: drugs, devices, and other interventions . 2015,第4期

机译：比伐卢定对肝素加糖蛋白IIb / IIIa抑制剂在接受经皮冠状动脉介入治疗的糖尿病患者中的作用：一项随机对照试验的荟萃分析
4. Influence of Diabetes Mellitus in patients with Long Coronary Lesions Undergoing Percutaneous Coronary Interventions: Multicenter PCI Registry in Japan [C] . E. Saito, M. Hirose, T. Miyauchi, International Congress on Coronary Artery Disease . 2003

机译：经皮冠状动脉干预患者糖尿病患者糖尿病的影响：日本多中心PCI登记处
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Coronary artery bypass surgery compared with percutaneous coronary interventions in patients with insulin-treated type 2 diabetes mellitus: a systematic review and meta-analysis of 6 randomized controlled trials [O] . Pravesh Kumar Bundhun, Zi Jia Wu, Meng-Hua Chen 2016

机译：胰岛素治疗的2型糖尿病患者的冠状动脉搭桥手术与经皮冠状动脉介入治疗的比较：6项随机对照试验的系统评价和荟萃分析
7. Impact of Bleeding on Mortality After Percutaneous Coronary Intervention Results From a Patient-Level Pooled Analysis of the REPLACE-2 (Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events), ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy), and HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trials [O] . Mehran, Roxana, Pocock, Stuart, Nikolsky, Eugenia, 2011

机译：经皮冠状动脉介入治疗后出血对死亡率的影响来自对REPLACE-2（将PCI链接血管造影最大程度减少临床事件的随机评估），急性（急性导管插入和紧急介入分流策略）的患者水平汇总分析的患者水平汇总分析（在急性心肌梗死中通过血运重建和支架使结果一致）试验

Use of Bivalirudin During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus An Analysis From the Randomized Evaluation in Percutaneous Coronary Intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 Trial

著录项

引文网络

相似文献

相关主题

期刊订阅